loader image
Friday, November 28, 2025
74 F
McAllen
- Advertisement -

Cala Trio™; The first non-invasive personalized therapy for hand tremors

Translate to Spanish or other 102 languages!

Source information: https://calatrio.com 

Mega Doctor News

- Advertisement -

The first targeted, wearable therapy designed to treat essential tremor (ET). The therapy delivers meaningful results for most patients after just a single session. Cala Trio™ requires a prescription from a medical doctor.

Source information: https://calatrio.com 

The Science

Surface stimulation delivered at your wrist is thought to disrupt the central tremor network in your brain that causes the hand tremor.

- Advertisement -
  • Developed through Clinical Studies
  • 64% of patients reported having persistent relief for an average of 94 minutes
  • 54% of patient’s tremor power improved by at least 50%

See if it’s right for you

A new approach to managing essential tremor

Non-invasive

Source information: https://calatrio.com 

Cala Trio™ is a wrist worn wearable therapy. No surgery or invasive procedures needed.

Drug Free

Source information: https://calatrio.com 

Tremor reduction without systemic side effects and drug interactions. A new individualized solution for essential tremor that fits with the flow of your life.

Easy to Try

Source information: https://calatrio.com 

There is no perfect treatment for everyone. If Cala Trio™ is not right for you, simply return within 60 days for a full refund less the $99 trial fee.

- Advertisement -

Results

The image below is an actual patient test (Archimedes Spiral Task) before and after a 40-minute stimulation therapy with Cala Trio.

Indications for Use

Cala Trio is indicated to aid in the transient relief of hand tremors in the treated hand following stimulation in adults with essential tremor. Please refer to the Safety Information for a complete listing of warnings and cautions.

Caution: Federal law restricts this device to sale by or on the order of a physician.

Visit https://calatrio.com for more information. All information is sourced from this site. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.

Educating Older Adults On Age-Related Weight Gain, Dec. 5th

The “Living with Weight Gain” program is part of STHS & Prominence Health’s “Senior Living Seminar Series,” which focuses on providing essential education on common health issues affecting the elderly population
- Advertisement -
×